Hypoparathyroidism Patient Experience Scales (HPES) are validated PRO measures focusing on disease-specific symptoms and impact on HRQoL. They assess the individual patient experience in a 2-week recall period.
HPES use standardised language and scales to assess the symptom and HRQoL impacts of hypoparathyroidism, independently of medical treatment choice. They may be used to support discussions between HCPs and patients.
HPES were developed in accordance with FDA guidance on best practice for PRO measure development.